Based in Oxford, England, Oxford Sciences Innovation (OSI) specializes in investments in spin-outs from Oxford University’s technology, mathematical, physical, life sciences and medical sciences departments.
Oxford Nanopore’s goal is to enable the analysis of any living thing, by anyone,anywhere. The Company has developed the world's first and only nanopore DNA sequencing platform, which is uniquely scalable from pocket-sized formats through to ultra-high throughput devices.
Oxford Investment Consultants LLP is an investment advisor that covers life sciences, healthcare and technology in the United Kingdom. The firm prefers to make investments in the University of Oxford spin out companies. Oxford Investments Consultants LLP is based in the United Kingdom.
Summary to be updated
Read more ›
2019-07-01 15:16 GTHCAP SHANGHAI, June 11, 2019 /PRNewswire/ -- GT Apeiron Therapeutics ("Apeiron"), a novel biotechnology company, was launched with the backing from GT Healthcare and associated investors.
Read more ›
